Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 188,672 shares at $2.65 ($500K) on 2017-08-31, disclosed to the SEC on 2017-09-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.65 | 94,336 | $250K | 50.0% |
| 2 | $2.65 | 94,336 | $250K | 50.0% |
| Total | $2.65 avg | 188,672 | $500K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |